A detailed history of Quadrant Capital Group LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 215 shares of TWST stock, worth $7,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares
215
Previous 156 37.82%
Holding current value
$7,931
Previous $7,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$36.72 - $58.88 $2,166 - $3,473
59 Added 37.82%
215 $9,000
Q2 2024

Aug 12, 2024

BUY
$27.95 - $53.0 $279 - $530
10 Added 6.85%
156 $7,000
Q4 2023

Feb 08, 2024

SELL
$15.08 - $38.61 $1,115 - $2,857
-74 Reduced 33.64%
146 $5,000
Q3 2023

Nov 14, 2023

SELL
$18.62 - $26.57 $614 - $876
-33 Reduced 13.04%
220 $4,000
Q2 2023

Aug 09, 2023

BUY
$11.49 - $20.46 $2,252 - $4,010
196 Added 343.86%
253 $5,000
Q1 2023

May 11, 2023

SELL
$14.6 - $30.9 $204 - $432
-14 Reduced 19.72%
57 $0
Q4 2022

Feb 10, 2023

SELL
$21.92 - $39.37 $6,137 - $11,023
-280 Reduced 79.77%
71 $1,000
Q3 2022

Nov 10, 2022

SELL
$33.44 - $56.56 $167 - $282
-5 Reduced 1.4%
351 $12,000
Q2 2022

Aug 09, 2022

BUY
$26.2 - $54.0 $9,248 - $19,062
353 Added 11766.67%
356 $12,000
Q1 2022

May 06, 2022

SELL
$38.58 - $83.27 $77 - $166
-2 Reduced 40.0%
3 $0
Q4 2021

Feb 01, 2022

SELL
$75.47 - $135.88 $6,490 - $11,685
-86 Reduced 94.51%
5 $0
Q3 2021

Nov 12, 2021

BUY
$95.64 - $131.48 $8,511 - $11,701
89 Added 4450.0%
91 $10,000
Q2 2021

Aug 09, 2021

SELL
$88.13 - $142.06 $1,762 - $2,841
-20 Reduced 90.91%
2 $0
Q1 2021

May 12, 2021

BUY
$105.48 - $207.97 $2,320 - $4,575
22 New
22 $3,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.08B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.